Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.

Among the total systemic sclerosis cohort, 14% of individuals were categorized as frail and 53% as prefrail, with frailty status linked to an increased risk for mortality.

Columnist Candace Semien applies the concept of radical responsibility to managing lupus and other chronic health conditions.

The Lupus Foundation of America is a nonprofit whose mission is to "improve the quality of life for all people affected by ...

A NEW Swedish study has found that menopausal hormone therapy (MHT) may be associated with an increased risk of developing ...

The following is a summary of “Barriers and facilitators to sustaining a lupus patient decision aid in regular rheumatology ...

People with lupus are at an increased risk of depression. Lupus is a chronic condition with recurring symptoms that can ...

Roche’s subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company targets the billion-dollar lupus market for its CD20-targeting drug Gazyva ...

Cutaneous lupus erythematosus (CLE) is an autoimmune disease whose pathophysiology is incompletely understood ... primarily while patients were not on systemic therapy to avoid medication effects on ...

Topical mupirocin helps reduce inflammation in lupus, offering a potential new approach for managing symptoms and improving ...

EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.

Your gut microbiome can trigger an immune response, leading to chronic systemic inflammation and lupus. Here are some tips to ...